Back
Clean Energy Fuels 10K Form
Sell
10
CLNE
Clean Energy Fuels
Last Price:
$1.68
Seasonality Move:
13.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | CLNE/Clean Energy Fuels Quarterly |
| 2024-02-29 | 10K | CLNE/Clean Energy Fuels Annual |
| 2023-11-09 | 10Q | CLNE/Clean Energy Fuels Quarterly |
| 2023-08-09 | 10Q | CLNE/Clean Energy Fuels Quarterly |
| 2023-05-09 | 10Q | CLNE/Clean Energy Fuels Quarterly |
| 2023-02-28 | 10K | CLNE/Clean Energy Fuels Annual |
Receive CLNE News And Ratings
See the #1 stock for the next 7 days that we like better than CLNE
CLNE Financial Statistics
Sales & Book Value
| Annual Sales: | $415.9M |
|---|---|
| Cash Flow: | $3.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.19 |
| Price / Book: | 0.55 |
Profitability
| EPS (TTM): | -0.36000 |
|---|---|
| Net Income (TTM): | $-83.1M |
| Gross Margin: | $83.6M |
| Return on Equity: | -11.4% |
| Return on Assets: | -6.67% |
Clean Energy Fuels Earnings Forecast
Key Clean Energy Fuels Financial Ratios
-
The Gross Profit Margin over the past 22 years for CLNE is 20.10%.
-
The Selling, General & Administrative Expenses for CLNE have been equal to 26.89% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of CLNE is -19.98% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 11 years.
Clean Energy Fuels Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | CLNE |
| CUSIP: | 184499 |
| Website: | cleanenergyfuels.com |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 2.67 |
| Quick Ratio: | 2.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 225.69 |
CLNE Technical Analysis vs Fundamental Analysis
Sell
10
Clean Energy Fuels (CLNE)
is a Sell
Is Clean Energy Fuels a Buy or a Sell?
-
Clean Energy Fuels stock is rated a SellThe current Clean Energy Fuels [CLNE] share price is $1.67. The Score for CLNE is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.